index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques

Dernières publications

Chiffres clés

59 Publications avec texte intégral

Open Access

47 %

Mots clés

Genetic associations PBMC Experimental autoimmune myasthenia gravis EAMG COVID-19 Neuromuscular junction Th17 cells LMNA Exercise Myasthenia Gravis Interleukine-23 Puberty COX2 Interferon-β Quality of life Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype B cells Lamin A/C nuclei Gender Autoimmune disease Genetics Autoimmunity Interferon Cell-cell communication Myasthenia Gravis MG Thymectomy MG patients Il-23 Autoimmune diseases Acetylcholine receptor antibodies Early-onset myasthenia gravis Interferon type-I Antimir-150 Interferonopathy Ferrites Immune regulation CCL21 Acetylcholine receptor Heart failure Anticorps monoclonal Immune response Human myoblasts Germinal center CD31 Acides nucléiques endogènes Chemokines Transcriptome CTCF Experimental autoimmune myasthenia gravis Chronicity Fragile X syndromes Endogenous nucleic acids Myasthenia gravis Follicular hyperplasia Cardiomyopathy Interferon de type I Centres germinatifs ectopiques Complete Freund's adjuvant Auto-immunité Glucocorticoids Immunology and Microbiology Section Etiology Cytokines Interferon IFN Myoblasts Immunotherapy Innate immunity Germinal centers Gd T cells Interleukin 23 DICER Immunity Thymus Inflammation Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Interféron de type I CXCL13-CXCR5 Adaptive immunity Thymoma Chronic inflammation Animal models Thymic epithelial cells Cellules th17 BAFF Acetylcholine receptors Experimental mouse models Conduction disease FMR1 AChR antibodies Age Assay comparison Long-term follow-up Interferon type I Myasthénie grave Ectopic germinal centers Disease susceptibility M3243AG Experimental models Chemokine Clinical cell transplantation Inflammatory cytokines